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Abstract
Impaired diastolic filling is a main contributor to heart failure
with preserved ejection fraction (HFpEF), a syndrome with
increasing prevalence and no treatment. Both collagen and
the giant sarcomeric protein titin determine diastolic function.
Since titin’s elastic properties can be adjusted physiologically,
we evaluated titin-based stiffness as a therapeutic target. We
adjusted RBM20-dependent cardiac isoform expression in the
titin N2B knockout mouse with increased ventricular stiffness.
A ~50 % reduction of RBM20 activity does not only main-
tain cardiac filling in diastole but also ameliorates cardiac
atrophy and thus improves cardiac function in the N2B-
deficient heart. Reduced RBM20 activity partially normalized
gene expression related to muscle development and fatty acid
metabolism. The adaptation of cardiac growth was related to
hypertrophy signaling via four-and-a-half lim-domain pro-
teins (FHLs) that translate mechanical input into hypertrophy
signals. We provide a novel link between cardiac isoform
expression and trophic signaling via FHLs and suggest cardiac
splicing as a therapeutic target in diastolic dysfunction.
Key message
& Increasing the length of titin isoforms improves ventricu-
lar filling in heart disease.
& FHL proteins are regulated via RBM20 and adapt cardiac
growth.
& RBM20 is a therapeutic target in diastolic dysfunction.
Keywords Heart failure . Therapy .Mouse models . RNA
processing . Hypertrophy signaling
Introduction
Cardiovascular disease is the main cause of death worldwide
with increasing prevalence of heart failure [1]. Multiple envi-
ronmental and genetic factors contribute to heart failure in-
cluding age, sex, diabetes, kidney disease, inflammation, and
mutations in sarcomeric proteins such as titin or cardiac splice
factors such as the RNA binding motif 20 (RBM20) that reg-
ulates titin-based stiffness [2]. The giant sarcomeric protein
titin contributes to the diastolic properties of the heart. Titin
undergoes extensive posttranslational modifications and alter-
native splicing adapts its elastic properties to the demands of
the organism [3, 4]. The elastic PEVK and N2B regions sup-
port diastolic function, while differentially affecting cardiac
growth [5, 6]. The PEVK region serves as an entropic spring,
while the N2B region improves efficiency of the cardiac cycle
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via altered calcium sensitivity [7, 8]. Changes in titin isoform
expression relate primarily to the elastic PEVK, N2B, and
inter-adjacent immunoglobulin (IG) regions and are mediated
by RBM20, the first splice factor related to human heart dis-
ease [9]. Patients withmutations in Rbm20 express more com-
pliant titin isoforms associated with dilated cardiomyopathy,
fibrosis, and sudden cardiac death [9, 10]. Both, a naturally
occurring RBM20-deficient rat strain and mice carrying a de-
letion of the RBM20 RNA recognition motif (RRM), express
similar giant titin isoforms and recapitulate human RBM20
deficiency [2, 11].
In mice, increased diastolic compliance associated
with longer titin isoforms contributes to improved cardi-
ac function [11]. In patients, the shift in titin isoform-
expression from the stiff N2B to the more compliant
N2BA isoform is also associated with improved function
[4, 12]. This change in titin-based elasticity compensates
for the increased ventricular stiffness by fibrosis. To
evaluate if cardiac splicing could serve as a therapeutic
target to decrease titin-based stiffness and could provide
a lasting beneficial effect on diastolic dysfunction, we
crossed the splice-deficient Rbm20ΔRRM mouse and the
titin N2B knockout mouse (Titin N2B−/−). Excision of
the elastic N2B element of titin affects the mechanical
properties of the sarcomere, hypertrophy signaling, and
ultimately leads to a restrictive filling pattern [5]. In
double-deficient mice (TitinΔN2B/ΔN2B Rbm20ΔRRM/WT),
reduced splicing with expression of more compliant titin
isoforms had several positive effects. Not only was dia-
stolic compliance improved but also cardiac dimensions,
RNA levels of genes related to the cAMP response, and
oxidative phosphorylation were restored. These findings
suggest that RBM20 could be a therapeutic target in
diastolic dysfunction.
Materials and methods
Animal procedures
Micewere sacrificed by cervical dislocation at 100 to 120 days
of age. The hearts were rapidly excised, washed in PBS, and
dissected into atria, septum, right and left ventricle, and tissues
were snap frozen in liquid nitrogen and stored at −80 °C. Mice
were age and sex matched for each analysis (100–120 days
old males). Generation of animal models and phenotyping by
histology, echocardiograpy and conductance catheter is de-
scribed in the supplement. All experiments involving animals
were carried out following the Guide for the Care and Use of
Laboratory Animals of the German animal welfare act and
protocols were approved by the Committee on the Ethics of
Animal Experiments of Berlin State authorities (LaGeSo).
Analysis and quantification of RNA and protein
expression
Proteins and RNA were extracted from left ventricular
tissue powder. Proteins were separated and blotted as de-
scribed previously [2]. Antibodies were used according to
manufacturer’s instructions and are listed in Supplemental
Table 1. Analysis of titin isoform expression was per-
formed as described previously [13]. TaqMan probes
(Supplemental Table 2), qRT-PCR conditions and analy-
sis, as well as RNAseq and global splicing analysis are
described in the supplement.
Statistics
Data are expressed as mean ± SEM. Multiple group compar-
isons were analyzed by two-way ANOVA. P values ≤ 0.05
were considered statistically significant.
Accession codes
All mouse RNA sequencing data have been submitted to the
NCBI sequence read archive (SRP091317).
Results
Reduced RBM20 expression restores cardiac dimensions
in titin N2B-deficient mice
We bred the N2B-KO as an animal model with diastolic dys-
function [5] with the splice-deficient RBM20 knockout mouse
lacking the RNA-binding domain (RBM20ΔRRM). This muta-
tion inefficiently removes titin I-band exons from the mature
transcript and therefore increases the length of titin’s spring
elements [11]. The resulting strain carries the homozygous
N2B deletion (N2B-KO) and the heterozygous deletion of
the RBM20 RRM domain (RBM20-HET). The animals dis-
play normal pre- and postnatal development, fertility, and
weight gain (Supplemental Fig. S1a, b). We refer to these
animals as Bsplice-rescue^ mice (N2B-KO RBM20-HET;
Fig. 1a). The N2B-deficient giant titin isoforms are expressed
in similar amounts as the giant isoforms in RBM20-HET and
run at the expected sizes in the titin gel. Loss of RBM20’s
RRM does not lead to compensatory upregulation of RBM20,
as RNA and protein expression over all RBM20 isoforms and
truncations were unchanged in RBM20-HET and splice-
rescue mice compared with the strains expressing wildtype
RBM20 (Fig. 1b).
The heart-to-body-weight ratio of the N2B-KO is reduced
[5], while heterozygous or homozygous deletion of the
RBM20-RRM domain does not alter cardiac size [11].
Introduction of the RBM20ΔRRM allele into the N2B-KO
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reverts cardiac atrophy in splice-rescue animals: The heart-to-
body-weight ratio is similar to wildtype levels (Fig. 1c) and
ventricular geometry is restored as determined by trichrome
staining of longitudinal cardiac slices (Fig. 1d). Neither the
histology nor the real-time PCR for collagen isoform 1a2
(Supplemental Fig. S1c) provides evidence for ventricular fi-
brosis, which was reported in rats with a heterozygous dele-
tion of RBM20 [2]. Trophic changes in the heart are usually
accompanied by the upregulation of hypertrophy markers
such as atrial natriuretic peptide (ANP) and brain natriuretic
peptide (BNP). In N2B-KO mice, ANP and BNP messenger
RNA (mRNA) levels are similar to WT mice, but both are
significantly elevated in left ventricles of RBM20-HET and
even more in splice-rescue mice compared with WT
(Supplemental Fig. S1c). Myofiber thickness was not signifi-
cantly different between genotypes (Supplemental Fig. S1d).
Diastolic function is improved in splice-rescue mice
The adaptation of cardiac size was validated by echocardio-
graphywith increased left ventricular inner diameter in systole
and diastole of splice-rescue compared with N2B-KO mice
(Fig. 2a). The calculated and measured heart-to-body-weight
ratios were consistent across genotypes with reduced cardiac
size only in the N2B-KO (Figs. 1c and 2b). Fractional short-
ening and ejection fraction were increased only in N2B-KO
mice, with no significant difference between WT and splice
rescue (Fig. 2c). To evaluate diastolic function, we used
Doppler imaging of mitral inflow and found an elevated E/A
ratio of N2B-KO mice, consistent with increased ventricular
stiffness that results in less efficient filling (Fig. 2d). The E/A-
ratio is reverted to WT levels in splice-rescue mice indicating
normalized diastolic function. Other parameters of cardiac
function were largely unchanged between genotypes
(Supplemental Table 3).
As an independent method to evaluate diastolic function,
we used conductance catheter-derived pressure volume rela-
tions to quantify left ventricular mechanics. End-systolic pres-
sure was not changed between genotypes, but end-diastolic
pressure was significantly increased in the N2B-KO and re-
stored to wildtype levels in splice-rescue mice (Fig. 3a). End-
systolic and end-diastolic volumes were decreased in the
N2B-KO and increased in RBM20-HET, although not signif-
icantly (Supplement Table 4). Unlike maximum systolic pres-
sure, maximum velocity of contraction (dP/dt), and maximum
velocity of relaxation (−dP/dt), which were unchanged
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Fig. 1 Reduced RBM20-dependent alternative splicing restores cardiac
dimensions in titin N2B knockout hearts. a Titin isoform expression of
left ventricles fromwildtype (WT) vs. heterozygous RBM20-deficient (R)
and N2B knockout (N) vs. compound RBM20/N2B-deficient animals
(NR). b Protein and RNA expression analysis of RBM20.
Representative western blot of RBM20 and the quantification normalized
to β-tubulin in WT, RBM20-HET, N2B-KO, and splice-rescue mice
(n = 6 for each group). Quantification of Rbm20 mRNA expression
normalized to Eef1a1 (n = 5–6 for each group). c Heart weight (HW) to
body weight (BW) ratios (n = 8–10 for each group). d Representative
longitudinal images ofMasson’s trichrome-stained hearts with ventricular
area indicated by the dashed line. Scale bar, 1 mm; original magnifica-
tion, ×5. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (b, c)
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between groups (Fig. 3b; Supplemental Table 4), the end-
diastolic pressure-volume relationship (EDPVR) of N2B-KO
was significantly increased compared with all other groups
(Fig. 3c). The reduced function of RBM20 restores EDPVR
in splice-rescue mice to WT levels indicating normalized dia-
stolic filling of the heart (Fig. 3c). The end-systolic pressure-
volume relationship (ESPVR) and the preload recruitable
stroke work (PRSW) were unchanged between groups
(Fig. 3c). Combined, this data confirms the echocardiography
findings of reverted diastolic dysfunction (Fig. 2d).
Splice-rescue mice exhibit molecular adaptations
to improve energy metabolism
To evaluate the regulation of gene expression associated with
the trophic changes in the splice rescue, we used high-
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Fig. 2 Heterozygous loss of
RBM20 normalizes cardiac
function in titin N2B-KO mice.
Data in (a–c) were obtained by
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Fig. 3 Reduced RBM20 activity decreases diastolic stiffness in N2B-KO
hearts. Data in (a–d) were obtained by cardiac catheterization. a End-
systolic (ESP) and end-diastolic (EDP) pressures in the four experimental
groups (n = 8–10 for each group). b Changes in maximum velocity of
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cardial contractility (n = 6–9 for each group). *P < 0.05; **P < 0.01
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throughput sequencing. The major transcriptional effect re-
sults from the heterozygous RBM20 deficiency, as pairwise
comparisons between strains where only one group is RBM20
deficient produces 514 vs. 743 significantly deregulated tran-
scripts. The knockout of titin’s N2B region accounts for 101
differentially regulated transcripts on the WT background and
225 transcripts on the RBM20-deficient background (Fig. 4a).
To differentiate the benefit and adverse effects of introducing
RBM20 deficiency in the N2B-KO on the molecular level, we
identified transcripts with misregulated and transcripts with
reverted expression after introduction of the Rbm20-
deficient allele (Fig. 4b). The mutated Rbm20 allele caused
an additional deregulation of 531 genes, which were not af-
fected in the N2B-KO compared with WT (misregulated).
Among the 101 genes differentially regulated between N2B-
KO andWT, 71 genes were no longer differentially expressed
in the splice-rescue animals (reverted). These 71 genes relate
to the regulation of fatty acid and carbohydrate metabolism, as
well as the cellular response to cAMP as determined by path-
way enrichment analysis (gene ontology–biological process-
es; Fig. 4c). Reverted and misregulated genes were classified
according to the gene ontology biological process terms, cel-
lular component, and molecular function using Cytoscape
(Fig. 4d). Genes with restored expression in the splice-
rescue animals (reverted) relate to muscle development and
metabolism (Fig. 4d). The gene products are enriched for lo-
calization in the respiratory chain (Fig. 4d; Supplemental
Fig. S2) and relate to growth factor and amino acid binding
or oxidoreductase activity. The misregulated genes are in-
volved in cardiac development, migration, and cell adhesion
indicating a role in remodeling. The gene products are located
in the extracellular matrix and contractile fibers (binding actin)
and relate to ion transport and actin binding. Together the
expression changes between the N2B-KO with diastolic dys-
function and the splice-rescue animal suggest normalization
of cardiac metabolism and altered remodeling.
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Fig. 4 Whole transcriptome analysis by RNAseq. a Matrix of
differentially regulated genes between WT, RBM20-HET, N2B-KO,
and splice-rescue mice (P < 0.05; n = 2 for N2B-KO, n = 3 for other
groups). Each square provides the number of differentially expressed
genes per comparison. Color intensity reflects the gene count as indicated
by the heat map. bOf the six possible comparisons between experimental
groups, we focused differences of wildtype to the three mutants (WT/N,
WT/R, WT/NR) and the comparison of N2B-KO with the splice rescue
(N/NR). Genes differentially expressed betweenWTandN2B-KO but not
between WT and splice rescue were normalized by reduced RBM20
activity (reverted genes). Genes differentially expressed between WT
and splice rescue but not between WT and N2B-KO were additionally
regulated by reduced RBM20 levels (misregulated genes). c Enrichment
analysis of reverted genes (top 5 biological processes ranked by P value).
d The reverted genes andmisregulated genes were classified by their gene
ontology
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Decreased functional RBM20 protein shifts cardiac
isoform expression
To identify the murine splice targets of RBM20 and evaluate
their contribution to improving the cardiac phenotype of N2B-
KO mice, we analyzed the differential isoform expression
between WT, RBM20-HET, N2B-KO, and splice-rescue
mice. The exon level analyses independently validated the
genotyping results and the heterozygous deletion of exons 6
and 7 of Rbm20 in RBM20-HET and splice-rescue mice
(Fig. 5a, c) and the homozygous deletion of the N2B element
in N2B-KO and splice-rescue mice (Fig. 5b, d). In both, the
RBM20 heterozygous and N2B-KO animals, we find partial
compensation at the knockout locus: heterozygous deletion of
Rbm20 does not lead to the expected 50 % reduction in
Rbm20 exons 6 and 7, suggesting upregulation of the WT
vs. KO allele on the transcript level (Fig. 5a, c). Along the
titin elastic region, additional exons encoding PEVK and IG
domains are included in the final N2B-deficient transcript as
PSI values of these exons are increased in N2B-KO vs. WT
(Fig. 5d). In N2B-KOmice, changes in isoform expression are
largely confined to titin itself, as PSI values in other genes are
unchanged. The heterozygousmutation of Rbm20 in RBM20-
HET and splice-rescue mice leads to several changes in
isoform expression as compared with WTand N2B-KOmice.
In total, 106 genes were differentially affected on the exon
level (FDR <0.01). These potential substrates of murine
RBM20 relate to myofibril assembly, respiratory chain, the
ribosome, and the muscle myosin complex as determined by
gene ontology analysis (Supplemental Fig. S3). Thirty-nine
genes were consistently spliced between RBM20-HET and
splice rescue vs. WT, and five of them have previously been
identified as RBM20 binding transcripts [14].
The main target of RBM20-dependent splicing in the
mouse is titin. The heterozygous deletion of RBM20’s RRM
leads to an up to 4-fold increase in PSI values of alternative
exons in titin’s elastic region located between the N2B ele-
ment and the PEVK region (Fig. 5d). Several transcripts are
differentially spliced by RBM20, with exon skipping or alter-
native exon inclusion in Camk2d, Ldb3, Ttc17, Obscn, and
Ank3 (Fig. 5e–i). Camk2d and Ldb3 have been described as
RBM20 targets in the Rbm20-deficient rat [2, 14] and
obscurin—although not significantly regulated in the rat—
has been identified based on the physical interaction of the
transcript with RBM20 [14]. The newly identified RBM20-
dependent isoforms expressed from the Ttc17, Ank3, Fhl1,
Arhgap10, Cflar, Hmgb1, and Myh7 gene (Fig. 5;
Supplemental Fig. S4 and S6) relate to actin polymerization,
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sarcomere structure and mechanotransduction. A summary of
the gene functions and exons/domains affected is provided in
Supplemental Table 5. Importantly, we find one differentially
expressed isoform of the titin binding protein FHL1, with
differential inclusion of the first exon that includes the ATG
(Fig. 5j). RBM20 deficiency would increase inclusion of the
exon containing the translation start and thus increase FHL1
protein expression.
FHL1 expression is increased in splice-rescue hearts
To address the molecular basis of the restored cardiac dimen-
sions of splice-rescue mice, we analyzed the expression of
several proteins previously linked to cardiac hypertrophy sig-
naling such as Erk1/2, Akt, mTOR, NFATc1, and JNK. All
were unchanged between genotypes (Supplemental Fig. S5a–
e). In addition, we measured protein levels of the four-and-a-
half lim-domain proteins FHL1 to determine, if the additional
inclusion of the RBM20-dependent exon containing the ATG
would increase FHL1 levels vs. FHL2, which is not differen-
tially spliced by RBM20 (Fig. 6a, Supplemental Fig. S4e).
Both FHL1 and FHL2 have not only been linked to cardiac
hypertrophy signaling but also bind titin [15, 16]. FHL1 pro-
tein levels—predominantly the FHL1B isoform—are strongly
increased only in splice-rescue to WT (Fig. 6a, b). Left ven-
tricular mRNA levels are largely unchanged with minor up-
regulation of Fhl1 RNA in splice-rescue compared with WT
mice, suggesting posttranscriptional regulation (Fig. 6c).
Thus, the reversion of diastolic dysfunction and cardiac atro-
phy in N2B-KO mice by reduced expression of functional
RBM20 is dependent on titin’s mechanical properties and as-
sociated with a posttranscriptional effect on FHL1, which
links titin-based biomechanics to cardiac hypertrophy
signaling.
Discussion
Diastolic dysfunction is an important contributor to the path-
ophysiology of heart failure, and our recent identification of
RBM20 as a titin splice factor has provided a unique target to
adjust the diastolic properties of the heart [2]. We chose a
genetic approach to adjust alternative splicing and concertedly
affect multiple protein isoforms that adapt cardiac function in
the titin N2B-KO mouse. In this animal model, the loss of
titin’s heart-specific elastic N2B region leads to a complex
cardiac phenotype including diastolic dysfunction [5].
Combining the N2B mutant with a splice-directed therapeutic
approach allowed us to address the following questions: first,
can increased titin-based stiffness resulting from loss of one
elastic domain be compensated by the inclusion of another
structural region? Second, can synergistic adaptation of mul-
tiple mRNA isoforms restore a complex cardiac phenotype?
In the splice-rescue mouse, the diastolic dysfunction
resulting from the loss of the titin N2B domain is completely
restored, as determined by echocardiography and conductance
catheter analysis. It includes the reduced E/A ratio as a sign of
improved ventricular filling, normalized passive pressures,
and normalized pressure volume relations. These findings
not only suggest that adjusting exon inclusion via inhibition
of RBM20 can improve the biomechanical properties of the
heart. But also, they indicate that restoration of compliance
does not have to occur at the protein-domain that caused the
increase in stiffness, as the adjustment of PEVK and IG
domain-based elasticity can compensate for the altered N2B-
based stiffness. Furthermore, our data also indicate that even a
reduction of RBM20 function to only 50 % is sufficient to
restore diastolic function, increasing the therapeutic window
of an RBM20-directed therapy. These findings are significant
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Fig. 6 FHL1 and FHL2 levels are inversely regulated in splice-rescue
mice. a Representative western blot analysis of FHL1 and FHL2 expres-
sion levels in LV tissue of WT, RBM20-HET (R), N2B-KO (N), and
splice-rescue mice (NR). b Quantification of FHL1A, FHL1B, and
FHL2 protein expression normalized to β-tubulin (n = 6 for all groups).
(c) Quantification of Fhl1 and Fhl2 mRNA levels by TaqMan normalized
to Eef1a1 (n = 5–6) *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001
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in light of the series of unsuccessful attempts to significantly
improve cardiac function in patients with diastolic dysfunction
[17–20]. Finally, the reduced RBM20 activity affects the
whole organism but does not lead to an obvious extracardiac
phenotype (weight, fertility, grooming), indicating a suffi-
ciently large therapeutic window for the future development
of an RBM20 inhibitor.
In N2B-KO animals, reduced RBM20 activity not only
improved diastolic dysfunction but also reverted the cardiac
atrophy of titin N2B-deficient diastolic dysfunction model,
illustrated by heart-to-body-weight measurements, trichrome
stainings, echocardiography and hemodynamic catheter anal-
ysis. On the molecular level, we found a positive effect on
metabolic function as reflected in reverted expression of genes
related to fatty acid oxidation. This improvement could result
from a direct effect of the differential splicing of RBM20
substrates that relate to cardiac hypertrophy signaling. As a
secondary effect, improved diastolic function might change
ventricular geometry as filling is improved or reduce strain
of the ventricular wall that might lead to improved coronary
flow and thus increased availability of nutrients. On a molec-
ular level, altered titin-based elasticity could change localiza-
tion or stability of proteins that differentially bind to the ex-
tended vs. relaxed titin filament [6].
We used RNAseq analysis to evaluate which transcripts are
alternatively spliced dependent on RBM20. At the exon level,
we find several genes affected, with more than 50 potential
novel substrates of RBM20. These genes relate to the regula-
tion of relaxation of cardiac muscle and myofibril assembly,
which could explain part of the beneficial effect on the phe-
notype. Several genes are relevant to sarcomere structure and
the hypertrophy response. In addition to candidate genes with
relation to the improved cardiac phenotype, we thus identified
several RBM20 substrates, including Obscurin, which was not
significantly affected on the exon level in the RBM20-
deficient rat [2] but has been identified by the CLIP analysis
[14]. For select transcripts, we found differential exon inclu-
sion between RBM20-deficient and splice-rescue animals,
which indicates a feedback of increased titin-based stiffness
in the N2B-KO on alternative splicing and a potential primary
role in the restored cardiac function of splice-rescue animals.
Finally, the first exon level analysis of the titin N2B knockout
revealed an unexpected finding with increased inclusion of I-
band exons that would partially revert the increased stiffness
resulting from the loss of the N2B exon. As RBM20 protein
levels are not different between N2B knockout and wildtype
animals, this effect could be mediated at the posttranslational
level or via an RBM20-independent splice factor.
Secondary changes reflected in our analysis of the RNAseq
data at the gene level can indicate adverse effects of targeting
RBM20 or beneficial effects. Genes that are reverted, namely
deregulated in N2B-KO but no longer in the splice-rescue
animals, are indicative of a compensatory regulation. They
relate to the regulation of fatty acid oxidation and the cellular
response to cAMP. The reversion of genes related to beta
oxidation affects all steps of the electron transfer chain, sug-
gesting a concerted regulation resulting in improved energy
balance in the splice-rescue animals. Thus, positive effects of
a splice level therapeutic approach via RBM20 could syner-
gistically improve diastolic function, size and metabolism.
To investigate the molecular basis of the trophic phenotype,
we investigated the regulation of several hypertrophy path-
ways and their contribution to the restored cardiac size of
the splice-rescue animals. We have previously proposed that
the decreased trophic signaling in the N2B-KO heart is caused
by decreased protein levels of the titin N2B-binding protein
FHL2 [5]. Interestingly, not only the deletion of the N2B
region led to a decrease in FHL2 protein levels but also the
heterozygous deletion of RBM20’s RRM—although the ef-
fects were not additive (splice-rescue mice expressed similar
amounts of FHL2 as the N2B-KO). Thus, altered FHL2 pro-
tein levels are not sufficient to explain the increased cardiac
trophic signaling in splice-rescue mice. In addition to the de-
creased FHL2 protein level, we found a minor increase of the
titin binding protein FHL1 and a highly significant increase of
its alternative splice isoform FHL1B in splice-rescue mice
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Fig. 7 Splice-directed therapy in N2B KO mice with diastolic
dysfunction and cardiac atrophy. Loss of the elastic N2B region (blue)
leads to cardiac atrophy with reduced FHL2 and increased FHL1B
expression. Reducing RBM20 activity to 50 % (splice rescue) increases
exon retention both in titin’s I-band region (green) and in FHL1B.
Together the RBM20-dependent adaptation of cardiac splicing restores
titin-based elasticity and cardiac size and adapts FHL protein levels and
fatty acid (FA) metabolism
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(~7.5-fold increase compared with WT). FHL1 mRNA levels
were only mildly upregulated in splice-rescue mice and the
FHL1 isoform that differentially includes the ATG-exon to
improve translation only accounts for <10 % of the total
FHL1 mRNA. Thus, the increase in FHL1 protein levels oc-
curs at a posttranscriptional level and would be consistent with
increased translation or decreased degradation of FHL1.
FHL1 binds to titin’s N2B region, where it has been suggested
to form a complex, which induces hypertrophy via Raf,MEK1/2
and ERK2 [15, 21]. Here, we do not find significant changes
in ERK2 activity. Thus, the isolated increase in FHL1 protein
levels in the absence of titin’s N2B region links FHL1 to
mechanically induced trophic signaling that is independent
on the N2B region as a force sensor and the induction of Erk
phosphorylation. How the combination altered titin-based
wall stress and deregulation of FHL1 can increase trophic
signaling to restore cardiac size will have to be resolved in
future experiments.
In summary, we extended the RBM20 substrate spectrum
in the mouse and found several alternatively spliced genes that
relate to sarcomere structure and mechanosignaling. Reduced
expression of functional RBM20 in the N2B-KO leads to a
compensatory inclusion of titin I-band exons into the N2B-
deficient titin resulting in decreased titin-based stiffness.
Increased inclusion of the FHL1 exon containing the transla-
tional start in RBM20-deficient mice leads to the expected
increase in FHL1 protein levels (Figs. 6 and 7). Together,
these changes would not only improve the mechanical prop-
erties of the sarcomere but also should facilitate mechanically
induced hypertrophy signaling. Reduced RBM20 activity re-
verts both diastolic dysfunction as well as cardiac atrophy and
partially normalizes the expression of genes that relate to stri-
ated muscle development and fatty acid metabolism. The val-
idation of RBM20 as a therapeutic target in heart failure, com-
bined with our published RBM20 splice reporter assay [2],
could provide a suitable basis for the future development of
splice inhibitors to improve diastolic function.
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